{"id":"NCT02863419","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus","officialTitle":"Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-08-10","primaryCompletion":"2017-08-19","completion":"2018-03-30","firstPosted":"2016-08-11","resultsPosted":"2019-11-07","lastUpdate":"2022-07-20"},"enrollment":711,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"semaglutide","otherNames":[]},{"type":"DRUG","name":"liraglutide","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Oral Semaglutide","type":"EXPERIMENTAL"},{"label":"Liraglutide","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This trial is conducted globally. The aim of this trial is to investigate efficacy and safety of oral Semaglutide versus Liraglutide and versus Placebo in Subjects with Type 2 Diabetes Mellitus.","primaryOutcome":{"measure":"Change in HbA1c (Week 26)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"Oral Semaglutide 14 mg","deltaMin":-1.2,"sd":0.9},{"arm":"Liraglutide 1.8 mg","deltaMin":-1.1,"sd":0.9},{"arm":"Placebo","deltaMin":-0.1,"sd":0.7}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.0645"},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.0056"},{"comp":"OG000 vs OG002","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":108,"countries":["United States","Croatia","Czechia","Germany","Hungary","Japan","Latvia","Poland","Puerto Rico","Slovakia","South Africa","Ukraine","United Arab Emirates"]},"refs":{"pmids":["31186120","34472698","35373893","37775297","33660198","32267058","31903692"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":31,"n":285},"commonTop":["Nausea","Nasopharyngitis","Diarrhoea","Headache","Vomiting"]}}